Almost all older adults in Yogyakarta have received complete doses of the Sinovac vaccine
Yogyakarta (ANTARA) – Yogyakarta city will start booster or third dose vaccinations from Monday (January 17, 2022) at three locations–the city hall complex, Pembina state special school, and Diponegoro Monument, the COVID-19 Handling Task Force announced.
“(Booster) vaccinations will start on Monday in three locations, prioritized for older adults and public service officers,” an official from the local task force, Heroe Poerwadi, said here on Friday.
Residents will receive an invitation from village officials, he informed adding, the booster vaccination program will prioritize those whose eligibility has been confirmed by the PeduliLindungi application.
The program will target 3,600 residents on Monday, and each recipient is scheduled to receive an AstraZeneca dose, he said.
“The vaccines we have prepared (for third dose vaccinations) are from Pfizer and AstraZeneca. However, in the early stage, we will use AstraZeneca,” Poerwadi added.
According to the regulations, people who have received the complete Sinovac dose can receive Pfizer, AstraZeneca, or Moderna vaccines for the booster shot, he noted.
“Almost all older adults in Yogyakarta have received complete doses of the Sinovac vaccine,” he said.
Based on data, as many as 24 thousand older adults in the city are targeted to receive the third dose vaccination.
The task force assured that vaccine stocks in Yogyakarta are sufficient for the booster drive.
To boost community immunity against COVID-19, the Indonesian government launched a nationwide vaccination program on January 13, 2021. President Joko Widodo was the first vaccine recipient under the program.
According to data provided by the Health Ministry, as of January 14, 2022, nearly 174,761,411 Indonesians have received their first COVID-19 jab, while 119,191,724 have been fully vaccinated against the virus.
The Indonesian government officially rolled out third dose vaccinations for the public on January 12, 2022, targeting those aged 18 and above who have taken the second dose at least six months ago.